1. Cardiac medications and their association with cardiovascular events in incident dialysis patients: Cause or effect? 
Areef Ishani, Charles A. Herzog, Allan J. Collins, Robert N. Foley 
Kidney International 
Volume 65, Issue 3, Pages (March 2004)
DOI: /j x
Copyright © 2004 International Society of Nephrology Terms and Conditions

2. Figure 1
Association between baseline use of any calcium channel blocker (CCB) and various outcomes.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

3. Figure 2
Association between baseline use of any angiotensin-converting enzyme inhibitor (ACEI) and various outcomes.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

4. Figure 3
Association between baseline use of any HMG-CoA reductase inhibitor (statin) and various outcomes.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

5. Figure 4
Association between baseline use of any beta-blocker and various outcomes.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

6. Figure 5
Association between baseline use of any anti-platelet agent and various outcomes.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions